Agenus Inc. (AGEN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.97 |
| Open | 6.01 |
| Bid | 6.55 x 400 |
| Ask | 6.62 x 100 |
| Day's range | 6.00 - 6.65 |
| 52-week range | 4.78 - 32.00 |
| Volume | |
| Avg. volume | 892,745 |
| Market cap | 137.755M |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | 0.57 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical are part of the Zacks top Analyst Blog.
- Zacks
Agenus (AGEN) Tanks on Colorectal Cancer Study Interim Data
The FDA rejects the accelerated approval pathway for Agenus' (AGEN) BOT/BAL combination in relapsed/refractory microsatellite stable colorectal cancer patients.
- Zacks
IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?
IGM Biosciences (IGMS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
© 2024 Yahoo. All rights reserved.